Proton therapy and radiopharmacy vendor Ion Beam Applications (IBA) said that it and Zevacor Molecular have completed acceptance testing for a Cyclone 70 cyclotron installed at Zevacor's Noblesville, IN, facility.
The cyclotron reached full beam power at full energy just 10 months after delivery to the facility, IBA said. It is now fully operational for radioisotope production.
The main focus of the 70-MeV cyclotron will be commercial manufacturing of strontium-82 to ensure an ample U.S.-based supply of strontium-82/rubidium-82 generators for use in diagnosing cardiovascular disease, the company said.
